SPROGOE KENNETT

Track

Insider profile

SPROGOE KENNETT's trades of Ascendis Pharma A/S's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
196.36
Quantity 70,005
Value US$2,351,541
Transaction date
Proposed sale
Price
175.44
Quantity 8,557
Value US$623,347
Transaction date
Proposed sale
Price
428.05
Quantity 85,316
Value US$4,754,512
Transaction date
Proposed sale
Price
152.12
Quantity 7,719
Value US$1,174,249
Transaction date
Proposed sale
Price
129.13
Quantity 1,222
Value US$157,794
Transaction date
Proposed sale
Price
150.00
Quantity 3,892
Value US$583,800
Transaction date
Proposed sale
Price
102.66
Quantity 45,000
Value US$4,619,700
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-02 2026-03-02
PrS Proposed sale
70,005
196.36
US$2,351,541 		70,005 196.36 US$2,351,541
2025-12-02 2025-12-02
PrS Proposed sale
8,557
175.44
US$623,347 		8,557 175.44 US$623,347
2025-05-06 2025-05-06
PrS Proposed sale
85,316
428.05
US$4,754,512 		85,316 428.05 US$4,754,512
2025-03-04 2025-03-04
PrS Proposed sale
7,719
152.12
US$1,174,249 		7,719 152.12 US$1,174,249
2024-12-10 2024-12-10
PrS Proposed sale
1,222
129.13
US$157,794 		1,222 129.13 US$157,794
2024-03-05 2024-03-01
PrS Proposed sale
3,892
150.00
US$583,800 		3,892 150.00 US$583,800
2023-09-18 2023-09-18
PrS Proposed sale
45,000
102.66
US$4,619,700 		45,000 102.66 US$4,619,700